In pediatrics and in rare neurodevelopmental disorders, detecting even the smallest change in behavior or function is critical, and often challenging. Adopting strategic trial designs and targeted assessment selection or development improves your ability to make informed decisions about your drug development efforts.
Cogstate has a group of neuroscience experts specifically with pediatric and rare disease training that you can leverage to improve signal detection, increase trial efficiencies, and be more confident about your data. Learn how our endpoint data quality programs and digital cognitive tests can assist your team at Cogstate.com
#clinicaltrials #rarediseases #centralrating #centralraters #neuroscience
